相关实验视频
Updated: Jul 23, 2025

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.3K
慢性病中的他类药物 - 对动脉样硬化和细胞衰老的影响
Piotr Fularski1, Julia Krzemińska1, Natalia Lewandowska1
1Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland.
Cells
|July 14, 2023
概括
慢性病 (CKD) 加快细胞衰老和炎症,增加心血管疾病 (CVD) 的风险. 类他类药物通过抑制HMG-CoA减少酶,减缓动脉样硬化和衰老来抵消这些效应具有前途.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 生物遗传学 生物遗传学
背景情况:
- 慢性病 (CKD) 与细胞过早衰老和全身炎症有关.
- 功能障碍加剧了心血管疾病 (CVD) 的风险和死亡率.
- 氧化应激和炎症形成了一个有害的循环,是CKD中心血管疾病的关键驱动因素.
研究的目的:
- 探索CKD,细胞衰老,炎症和心血管疾病之间的关系.
- 确定导致CKD患者心血管疾病进展的机制.
- 评估他类药物在缓解CKD相关心血管风险方面的潜力.
主要方法:
- 关于CKD病理生理学和心血管并发症的文献综述.
- 分析包括尿素毒素积累,氧化应激和内皮功能障碍在内的机制.
- 检查炎症和细胞衰老在动脉样硬化中的作用.
主要成果:
- 慢性病患者表现出加速衰老和炎症,增加动脉样硬化风险.
- 机制包括尿素毒素,代谢障碍,氧化缺乏和活性氧物种 (ROS) 的增加.
- 通过抑制HMG-CoA减少酶,他类药物显示出减缓动脉样硬化和细胞衰老的潜力.
结论:
- 慢性瘤通过加速衰老和炎症显著增加心血管疾病的风险.
- 类药物代表了一种治疗策略,用于对抗CKD中这些有害过程.
- 针对氧化应激,炎症和衰老途径对于管理CKD中的心血管疾病至关重要.
相关概念视频
Chronic Kidney Disease I: Introduction
41
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
41
Chronic Kidney Disease III: Interprofessional Care
43
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
43
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
702
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
702
Chronic Kidney Disease II: Clinical Manifestations
35
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
35
Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
Factors Affecting Renal Clearance: Renal Impairment
123
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
123

